Regulus Therapeutics (RGLS) Tops Q3 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Regulus Therapeutics (RGLS) Tops Q3 EPS by 12c

Regulus Reports Third Quarter 2015 Financial Results and Recent Highlights

November 5, 2015 4:06 PM EST

LA JOLLA, Calif., Nov. 5, 2015 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results and highlights for the quarter ended September 30, 2015 and provided a summary of recent corporate highlights. 

"Regulus' recent achievements reflect our steady progress in building a meaningful clinical portfolio based on microRNAs," said Paul Grint,... More